These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24850316)

  • 61. Metabolic behavior prediction of pazopanib by cytochrome P450 (CYP) 3A4 by molecular docking.
    Liu XJ; Lu H; Sun JX; Wang SR; Mo YS; Yang XS; Shi BK
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):465-8. PubMed ID: 25737032
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Porcine cytochrome P450 3A: current status on expression and regulation.
    Rasmussen MK
    Arch Toxicol; 2020 Jun; 94(6):1899-1914. PubMed ID: 32172306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.
    Dahal UP; Joswig-Jones C; Jones JP
    J Med Chem; 2012 Jan; 55(1):280-90. PubMed ID: 22087535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro assessment of the photo(geno)toxicity associated with Lapatinib, a Tyrosine Kinase inhibitor.
    García-Lainez G; Vayá I; Marín MP; Miranda MA; Andreu I
    Arch Toxicol; 2021 Jan; 95(1):169-178. PubMed ID: 32815004
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro.
    Li YH; Lin QM; Pang NH; Zhang XD; Huang HL; Cai JP; Hu GX
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):337-344. PubMed ID: 31058459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel Homodimer Metabolites of GDC-0994 via Cytochrome P450-Catalyzed Radical Coupling.
    Takahashi RH; Grandner JM; Bobba S; Liu Y; Beroza P; Zhang D; Ma S
    Drug Metab Dispos; 2020 Jun; 48(6):521-527. PubMed ID: 32234735
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.
    Dang NL; Hughes TB; Miller GP; Swamidass SJ
    Chem Res Toxicol; 2018 Feb; 31(2):68-80. PubMed ID: 29355304
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites.
    Paludetto MN; Bijani C; Puisset F; Bernardes-Génisson V; Arellano C; Robert A
    J Med Chem; 2018 Sep; 61(17):7849-7860. PubMed ID: 30102538
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pyrimidine metabolism. IV. A comparison of normal and regenerating rat liver.
    CANELLAKIS ES; JAFFE JJ; MANTSAVINOS R; KRAKOW JS
    J Biol Chem; 1959 Aug; 234(8):2096-9. PubMed ID: 13673019
    [No Abstract]   [Full Text] [Related]  

  • 70. Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-
    Poggialini F; Vagaggini C; Brai A; Pasqualini C; Crespan E; Maga G; Perini C; Cabella N; Botta L; Musumeci F; Frosini M; Schenone S; Dreassi E
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839775
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.
    Ghosal A; Ramanathan R; Yuan Y; Hapangama N; Chowdhury SK; Kishnani NS; Alton KB
    Drug Metab Dispos; 2007 Dec; 35(12):2186-95. PubMed ID: 17827338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction.
    Zamperini C; Dreassi E; Vignaroli G; Radi M; Dragoni S; Schenone S; Musumeci F; Valoti M; Antiochia R; Botta M
    Drug Metab Pharmacokinet; 2014; 29(6):433-40. PubMed ID: 24850316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.
    Walsky RL; Obach RS; Hyland R; Kang P; Zhou S; West M; Geoghegan KF; Helal CJ; Walker GS; Goosen TC; Zientek MA
    Drug Metab Dispos; 2012 Sep; 40(9):1686-97. PubMed ID: 22645092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation.
    Zhu Y; Wang F; Li Q; Zhu M; Du A; Tang W; Chen W
    Drug Metab Dispos; 2014 Feb; 42(2):245-9. PubMed ID: 24301608
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.